EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cyclosporine pharmacokinetics in cats following topical ocular administration



Cyclosporine pharmacokinetics in cats following topical ocular administration



Transplantation 47(3): 516-519



Topical ocular administration of two forms of cyclosporine were studied in the cat. Both forms were able to produce measurable whole-blood levels capable of suppressing in vitro lymphocyte stimulation. The kinetics of cyclosporine following administration of either oral solution or cyclosporine in olive oil were variable, with peak concentrations ranging from 450 to 1033 ng/ml and 288 to 648 ng/ml, respectively. Absorption lag time ranged from 0 to 1.34 hr for oral solution, and 0.27 to 1.2 hr for cyclosporine in olive oil. The half-life of elimination ranged from 2.41 to 10.04 hr, and 3.09 to 15.75 hr, respectively. When compared with the commercially available oral solution, cyclosporine dissolved in olive oil was better tolerated during administration. Topical ocular administration of cyclosporine in cats offers a possible alternative method of treatment for individuals intolerant of oral administration. Topical ocular administration might also replace the need for intravenous administration of cyclosporine during perioperative periods or during periods of vomiting and nausea associated with rejection or other illnesses. Due to individual variation in absorption and elimination of topically applied cyclosporine, dosages in each cat must be determined by monitoring blood, plasma, or serum levels.

(PDF emailed within 0-6 h: $19.90)

Accession: 001790970

Download citation: RISBibTeXText

PMID: 2646782

DOI: 10.1097/00007890-198903000-00023



Related references

Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits. Cornea 32(3): 345-354, 2013

Ocular and systemic pharmacokinetics of lidocaine hydrochloride ophthalmic gel in rabbits after topical ocular administration. European Journal of Drug Metabolism and Pharmacokinetics 40(4): 409-415, 2016

Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease. Pharmaceutical Research 36(2): 36-36, 2019

Topical Cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber. Clao Journal 24(3): 159-165, 1998

Topical cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5 percent cyclosporine A into the cornea and anterior chamber. CLAO Journal 24(3): 159-165, 1998

Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies. Drug Delivery 25(1): 888-899, 2018

The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration. Ophthalmic Research 48(3): 139-145, 2012

Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs. Journal of Veterinary Pharmacology and Therapeutics 25(4): 265-272, 2002

Pharmacokinetics of terbinafine in the rabbit ocular tissues after topical administration. Ophthalmic Research 39(2): 81-83, 2007

Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits. Journal of Ocular Pharmacology and Therapeutics 31(1): 51-56, 2015

Ocular pharmacokinetics of radioactive dapiprazole after topical and parenteral administration. European Journal of Pharmacology 183(2): 396, 1990

Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits. Journal of Ocular Pharmacology and Therapeutics 32(7): 405-414, 2017

Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats. Methods and Findings in Experimental and Clinical Pharmacology 15(8): 527-534, 1993

Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration. Parasites & Vectors 9(1): 296-296, 2017

Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans. Journal of Ocular Pharmacology and Therapeutics 25(4): 335-344, 2009